SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-042566
Filing Date
2019-11-12
Accepted
2019-11-12 07:41:49
Documents
72
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q syrs-10q_20190930.htm 10-Q 2367164
2 EX-10.1 syrs-ex101_183.htm EX-10.1 206988
3 EX-31.1 syrs-ex311_8.htm EX-31.1 17534
4 EX-31.2 syrs-ex312_9.htm EX-31.2 17504
5 EX-32.1 syrs-ex321_6.htm EX-32.1 7420
6 EX-32.2 syrs-ex322_7.htm EX-32.2 7519
  Complete submission text file 0001564590-19-042566.txt   8075764

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT syrs-20190930.xml EX-101.INS 1632663
8 XBRL TAXONOMY EXTENSION SCHEMA syrs-20190930.xsd EX-101.SCH 56400
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE syrs-20190930_cal.xml EX-101.CAL 53550
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE syrs-20190930_def.xml EX-101.DEF 189089
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE syrs-20190930_lab.xml EX-101.LAB 438477
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE syrs-20190930_pre.xml EX-101.PRE 360577
Mailing Address 620 MEMORIAL DRIVE SUITE 300 CAMBRIDGE MA 02139
Business Address 620 MEMORIAL DRIVE SUITE 300 CAMBRIDGE MA 02139 617-744-1340
Syros Pharmaceuticals, Inc. (Filer) CIK: 0001556263 (see all company filings)

IRS No.: 453772460 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37813 | Film No.: 191206132
SIC: 2834 Pharmaceutical Preparations